Chromatin modifying activity of leukaemia associated fusion proteins

Human Molecular Genetics

Volumn 14, Issue SPEC. ISS. 1, 2005, Pages

  Di Croce, Luciano ^a  

^a CENTRE FOR GENOMIC REGULATION CRG   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE; HISTONE DEACETYLASE; HISTONE DEACETYLASE INHIBITOR; HYBRID PROTEIN; LEUKEMIA ANTIGEN; MIXED LINEAGE LEUKEMIA PROTEIN; ONCOPROTEIN; RETINOIC ACID; RETINOIC ACID RECEPTOR ALPHA; TRANSCRIPTION FACTOR RUNX1;

ACUTE LEUKEMIA; APOPTOSIS; CELL DIFFERENTIATION; CELL LINEAGE; CELL MATURATION; CELL PROLIFERATION; CELL SPECIFICITY; CHIMERA; CHROMATIN; CHRONIC LEUKEMIA; CLINICAL TRIAL; DNA METHYLATION; ENZYME ACTIVITY; ENZYME MODIFICATION; GENE CONTROL; GENE EXPRESSION; GENE FUSION; GENE TARGETING; GENETIC CODE; HEMATOPOIESIS; HEMATOPOIETIC CELL; HUMAN; LEUKEMIA; LYMPHATIC LEUKEMIA; MYELOID LEUKEMIA; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROTEIN FUNCTION; PROTEIN SYNTHESIS; RECIPROCAL CHROMOSOME TRANSLOCATION; REVIEW; STEM CELL;

AMINO ACID SEQUENCE; ANIMALS; CELL DIFFERENTIATION; CHROMATIN; CORE BINDING FACTOR ALPHA 2 SUBUNIT; DNA METHYLATION; DNA-BINDING PROTEINS; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HEMATOPOIESIS; HUMANS; LEUKEMIA; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; ONCOGENE PROTEINS, FUSION; PROTO-ONCOGENE PROTEINS; RECEPTORS, RETINOIC ACID; TRANSCRIPTION FACTORS;

EID: 17444390135     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/ddi109     Document Type: Review

References (64)

1. Kornberg, R.D. and Lorch, Y. (1999) Twenty-five years of the nucleosome, fundamental particle of the eukaryote chromosome. Cell, 98, 285-294.
2. Francis, N.J., Kingston, R.E. and Woodcock, C.L. (2004) Chromatin compaction by a Polycomb group protein complex. Science, 306, 1574-1577.
3. Dorigo, B., Schalch, T., Kulangara, A., Duda, S., Schroeder, R.R. and Richmond, T.J. (2004) Nucleosome arrays reveal the two-start organization of the chromatin fiber. Science, 306, 1571-1573.
4. Jenuwein, T. and Allis, C.D. (2001) Translating the histone code. Science, 293, 1074-1080.
5. Orphanides, G. and Reinberg, D. (2002) A unified theory of gene expression. Cell, 108, 439-451.
6. Yang, X.J. and Seto, E. (2003) Collaborative spirit of histone deacetylases in regulating chromatin structure and gene expression. Curr. Opin. Genet. Dev., 13, 143-153.
7. Lachner, M., O'Sullivan, R.J. and Jenuwein, T. (2003) An epigenetic road map for histone lysine methylation. J. Cell Sci., 116, 2117-2124.
8. Bannister, A.J., Zegerman, P., Partridge, J.F., Miska, E.A., Thomas, J.O., Allshire, R.C. and Kouzarides, T. (2001) Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain. Nature, 410, 120-124.
9. Fischle, W., Wang, Y., Jacobs, S.A., Kim, Y., Allis, C.D. and Khorasanizadeh, S. (2003) Molecular basis for the discrimination of repressive methyl-lysine marks in histone H3 by Polycomb and HP1 chromodomains. Genes Dev., 17, 1870-1881.
10. Wang, H., Huang, Z.Q., Xia, L., Feng, Q., Erdjument-Bromage, H., Strahl, B.D., Briggs, S.D., Allis, C.D., Wong, J., Tempst, P. et al. (2001) Methylation of histone H4 at arginine 3 facilitating transcriptional activation by nuclear hormone receptor. Science, 293, 853-857.
11. Shi, Y., Lan, F., Matson, C., Mulligan, P., Whetstine, J.R., Cole, P.A. and Casero, R.A. (2004) Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell, 119, 941-953.
12. Berger, S.L. (2002) Histone modifications in transcriptional regulation. Curr. Opin. Genet. Dev., 12, 142-148.
13. Fischle, W., Wang, Y. and Allis, C.D. (2003) Binary switches and modification cassettes in histone biology and beyond. Nature, 425, 475-479.
14. Bird, A. (2002) DNA methylation patterns and epigelletic memory. Genes Dev., 16, 6-21.
15. Li, E. (2002) Chromatin modification and epigenetic reprogramming in mammalian development. Nat. Rev. Genet., 3, 662-673.
16. Villa, R., de Santis, F., Gutierrez, A., Minucci, S., Pelicci, P.G. and Di Croce, L. (2004) Epigenetic gene silencing in acute promyelocytic leukemia. Biochem. Pharmacol., 68, 1247-1254.
17. Di Croce, L., Buschbeck, M., Gutierrez, A., Joval, I., Morey, L., Villa, R. and Minucci, S. (2004) Altered epigenetic signals in human disease. Cancer Biol. Ther., 3, 831-837.
18. Hendrich, B. and Bickmore, W. (2001) Human diseases with underlying defects in chromatin structure and modification. Hum. Mol. Genet., 10, 2233-2242.
19. Feinberg, A.P. and Tycko, B. (2004) The history of cancer epigenetics. Nat. Rev. Cancer, 4, 143-153.
20. Weissman, I.L., Anderson, D.J. and Gage, F. (2001) Stem and progenitor cells: origins, phenotypes, lineage commitments, and transdifferentiations. Annu. Rev. Cell Dev. Biol., 17, 387-403.
21. Look, A.T. (1997) Oncogenic transcription factors in the human acute leukemias. Science, 278, 1059-1064.
22. Kelly, L.M. and Gilliland, D.G. (2002) Genetics of myeloid leukemias. Annu. Rev. Genomics Hum. Genet., 3, 179-198.
23. Daser, A. and Rabbitts, T.H. (2004) Extending the repertoire of the mixed-lineage leukemia gene MLL in leukemogenesis. Genes Dev. 18, 965-974.
24. Nakamura, T., Mori, T., Tada, S., Krajewski, W., Rozovskaia, T., Wassell, R., Dubois, G., Mazo, A., Croce, C.M. and Canaani, E. (2002) ALL-1 is a histone methyltransferase that assembles a supercomplex of proteins involved in transcriptional regulation. Mol. Cell, 10 1119-1128.
25. Milne, T.A., Briggs, S.D., Brock, H.W., Martin, M.E., Gibbs, D., Allis, C.D. and Hess, J.L. (2002) MLL targets SET domain methyltransferase activity to Hox gene promoters. Mol. Cell, 10, 1107-1117.
26. Ayton, P.M. and Cleary, M.L. (2003) Transformation of myeloid progenitors by MLL oncoproteins is dependent on Hoxa7 and Hoxa9. Genes Dev., 17, 2298-2307.
27. Ayton, P.M., Chen, E.H. and Cleary, M.L. (2004) Binding to nonmethylated CpG DNA is essential for target recognition, transactivation, and myeloid transformation by an MLL oncoprotein. Mol. Cell. Biol., 24, 10470-10478.
28. Nie, Z., Yan, Z., Chen, E.H., Sechi, S., Ling, C., Zhou, S., Xue, Y., Yang, D., Murray, D., Kanakubo, E. et al. (2003) Novel SWI/SNF chromatin-remodeling complexes contain a mixed-lineage leukemia chromosomal translocation partner. Mol. Cell. Biol., 23, 2942-2952.
29. Jaju, R.J., Fidler, C., Haas, O.A., Strickson, A.J., Watkins, F., Clark, K., Cross, N.C., Cheng, J.F., Aplan, P.D., Kearney, L. et al. (2001) A novel gene, NSD1, is fused to NUP98 in the t(5;11)(q35;p15.5) in de novo childhood acute myeloid leukemia. Blood, 98, 1264-1267.
30. Rosati, R., La Starza, R., Veronese, A., Aventin, A., Schwienbacher, C., Vallespi, T., Negrini, M., Martelli, M.F. and Mecucci, C. (2002) NUP98 is fused to the NSD3 gene in acute myeloid leukemia associated with t(8;11)(p11.2;p15). Blood, 99, 3857-3860.
31. Nimer, S.D. and Moore, M.A. (2004) Effects of the leukemia-associated AML1-ETO protein on hematopoietic stem and progenitor cells. Oncogene, 23, 4249-4254.
32. Hug, B.A. and Lazar, M.A. (2004) ETO interacting proteins. Oncogene, 23, 4270-4274.
33. Jones, L.K. and Saha, V. (2002) Chromatin modification, leukaemia and implications for therapy. Br. J. Haematol., 118 714-727.
34. Zhang, J., Kalkum, M., Yamamura, S., Chait, B.T. and Roeder, R.G. (2004) E protein silencing by the leukemogenic AML1-ETO fusion protein. Science, 305, 1286-1289.
35. Zelent, A., Greaves, M. and Enver, T. (2004) Role of the TEL-AML1 fusion gene in the molecular pathogenesis of childhood acute lymphoblastic leukaemia. Oncogene, 23, 4275-4283.
36. Greaves, M.F., Maia, A.T., Wiemels, J.L. and Ford, A.M. (2003) Leukemia in twins: lessons in natural history. Blood, 102 2321-2333.
37. Durst, K.L. and Hiebert, S.W. (2004) Role of RUNX family members in transcriptional repression and gene silencing. Oncogene, 23, 4220-4224.
38. Borrow, J., Stanton, V.P., Jr., Andresen, J.M., Becher, R., Behm, F.G., Chaganti, R.S., Civin, C.I., Disteche, C., Dube, I., Frischauf, A.M. et al. (1996) The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB-binding protein. Nat. Genet., 14, 33-41.
39. Chaffanet, M., Gressin, L., Preudhomme, C., Soenen-Cornu, V., Birnbaum, D. and Pebusque, M.J. (2000) MOZ is fused to p300 in an acute monocytic leukemia with t(8;22). Genes Chromosomes Cancer, 28 138-144.
40. Deguchi, K., Ayton, P.M., Carapeti, M., Kutok, J.L., Snyder, C.S., Williams, I.R., Cross, N.C., Glass, C.K., Cleary, M.L. and Gilliland, D.G. (2003) MOZ-TIF2-induced acute myeloid leukemia requires the MOZ nucleosome binding motif and TIF2-mediated recruitment of CBP. Cancer Cell, 3, 259-271.
41. Panagopoulos, I., Fioretos, T., Isaksson, M., Samuelsson, U., Billstrom, R., Strombeck, B., Mitelman, F. and Johansson, B. (2001) Fusion of the MORF and CBP genes in acute myeloid leukemia with the t(10;16)(q22;p13). Hum. Mol. Genet., 10, 395-404.
42. Zelent, A., Guidez, F., Melnick, A., Waxman, S. and Licht, J.D. (2001) Translocations of the RARalpha gene in acute promyelocytic leukemia. Oncogene, 20, 7186-7203.
43. Pandolfi, P.P. (2001) Oncogenes and tumor suppressors in the molecular pathogenesis of acute promyelocytic leukemia. Hum. Mol. Genet., 10, 769-775.
44. Dong, S., Stenoien, D.L., Qiu, J., Mancini, M.A. and Tweardy, D.J. (2004) Reduced intranuclear mobility of APL fusion proteins accompanies their mislocalization and results in sequestration and decreased mobility of retinoid X receptor alpha. Mol. Cell. Biol., 24, 4465-4475.
45. Di Croce, L., Raker, V.A., Corsaro, M., Fazi, F., Fanelli, M., Faretta, M., Fuks, F., Lo Coco, F., Kouzarides, T., Nervi, C. et al. (2002) Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor. Science, 295, 1079-1082.
46. Duprez, E., Wagner, K., Koch, H. and Tenen, D.G. (2003) C/EBPbeta: a major PML-RARA-responsive gene in retinoic acid-induced differentiation of APL cells. EMBO J., 22, 5806-5816.
47. Thompson, A., Quinn, M.F., Grimwade, D., O'Neill, C.M., Ahmed, M.R., Grimes, S., McMullin, M.F., Cotter, F. and Lappin, T.R. (2003) Global down-regulation of HOX gene expression in PML-RARalpha + acute promyelocytic leukemia identified by small-array real-time PCR. Blood, 101, 1558-1565.
48. Park, D.J., Vuong, P.T., de Vos, S., Douer, D. and Koeffler, H.P. (2003) Comparative analysis of genes regulated by PML/RAR alpha and PLZF/RAR alpha in response to retinoic acid using oligonucleotide arrays. Blood, 102, 3727-3736.
49. Alcalay, M., Meani, N., Gelmetti, V., Fantozzi, A., Fagioli, M., Orleth, A., Riganelli, D., Sebastiani, C., Cappelli, E., Casciari, C. et al. (2003) Acute myeloid leukemia fusion proteins deregulate genes involved in stem cell maintenance and DNA repair. J. Clin. Invest., 112, 1751-1761.
50. Kamashev, D., Vitoux, D. and de The, H. (2004) PML-RARA-RXR oligomers mediate retinoid and rexinoid/cAMP cross-talk in acute promyelocytic leukemia cell differentiation. J. Exp. Med., 199 1163-1174.
51. Insinga, A., Pelicci, P.G. and Minucci, S. (2005) Leukemia-associated fusion proteins: multiple mechanisms of action to drive cell transformation. Cell Cycle, 4, 67-69.
52. He, L.Z., Bhaumik, M., Tribioli, C., Rego, E.M., Ivins, S., Zelent, A. and Pandolfi, P.P. (2000) Two critical hits for promyelocytic leukemia. Mol. Cell, 6, 1131-1141.
53. Insinga, A., Monestiroli, S., Ronzoni, S., Gelmetti, V., Marchesi, F., Viale, A., Altucci, L., Nervi, C., Minucci, S. and Pelicci, P.G. (2005) Inhibitors of histone deacetylases induce tumor-selective apoptosis through activation of the death receptor pathway. Nat. Med. 11, 71-76.
54. Nebbioso, A., Clarke, N., Voltz, E., Germain, E., Ambrosino, C., Bontempo, P., Alvarez, R., Schiavone, E.M., Ferrara, F., Bresciani, F. et al. (2005) Tumor-selective action of HDAC inhibitors involves TRAIL induction in acute myeloid leukemia cells. Nat. Med., 11 77-84.
55. Kelly, L.M., Liu, Q., Kutok, J.L., Williams, I.R., Boulton, C.L. and Gilliland, D.G. (2002) FLT3 internal tandem duplication mutations associated with human acute myeloid leukemias induce myeloproliferative disease in a murine bone marrow transplant model. Blood, 99, 310-318.
56. Walter, M.J., Park, J.S., Lau, S.K., Li, X., Lane, A.A., Nagarajan, R., Shannon, W.D. and Ley, T.J. (2004) Expression profiling of murine acute promyelocytic leukemia cells reveals multiple model-dependent progression signatures. Mol. Cell. Biol., 24, 10882-10893.
57. Barna, M., Merghoub, T., Costoya, J.A., Ruggero, D., Branford, M., Bergia, A., Samori, B. and Pandolfi, P.P. (2002) Plzf mediates transcriptional repression of HoxD gene expression through chromatin remodeling. Dev. Cell, 3, 499-510.
58. Lund, A.H. and van Lohuizen, M. (2004) Epigenetics and cancer. Genes Dev., 18, 2315-2335.
59. Jones, P.A. and Baylin, S.B. (2002) The fundamental role of epigenetic events in cancer. Nat. Rev. Genet., 3, 415-428.
60. Egger, G., Liang, G., Aparicio, A. and Jones, P.A. (2004) Epigenetics in human disease and prospects for epigenetic therapy. Nature, 429, 457-463.
61. So, C.W. and Cleary, M.L. (2004) Dimerization: a versatile switch for oncogenesis. Blood, 104, 919-922.
62. Cameron, E.E., Bachman, K.E., Myohanen, S., Herman, J.G. and Baylin, S.B. (1999) Synergy of demethylation and histone deacetylase inhibition in the re- expression of genes silenced in cancer. Nat. Genet., 21, 103-107.
63. Zhou, D.C., Kim, S.H., Ding, W., Schultz, C., Waffell, R.P., Jr and Gallagher, R.E. (2002) Frequent mutations in the ligand-binding domain of PML-RARalpha after multiple relapses of acute promyelocytic leukemia: analysis for functional relationship to response to all- trans retinoic acid and histone deacetylase inhibitors in vitro and in vivo. Blood, 99, 1356-1363.
64. Claus, R. and Lubbert, M. (2003) Epigenetic targets in hematopoietic malignancies. Oncogene, 22, 6489-6496.